Sign in

CIK 0000907654

  • Non-accelerated filer
  • Smaller reporting company

Oruka Therapeutics, Inc.

Sign in to watch
Ticker
ORKA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
363855489
Phone
+1 650-606-7910
Business address
855 OAK GROVE AVE., SUITE 100, MENLO PARK, CA, 94025
Former names
ARCA biopharma, Inc., NUVELO INC, HYSEQ INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$20,577,126
in 17 filings, $20.2M under 10b5-1 plans

Net −$20,577,126. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2022-04-07 Funicular Fund, LP See Footnote 1 Purchase +27,450 $2.32 $64K 2,048,977
2022-04-06 Funicular Fund, LP See Footnote 1 Purchase +26,806 $2.30 $62K 2,021,527
2022-04-05 Funicular Fund, LP See Footnote 1 Purchase +49,728 $2.30 $114K 1,994,721
2022-04-04 Funicular Fund, LP See Footnote 1 Purchase +122,342 $2.26 $276K 1,944,993
2022-04-04 Funicular Fund, LP See Footnote 1 Purchase +122,342 $2.26 $276K 1,944,993
2021-12-14 Ozeroff Christopher David S.V.P., General Counsel Grant or award · Stock Option (right to buy) +27,500 27,500
2021-12-14 Keuer Thomas A Chief Operating Officer Grant or award · Stock Option (right to buy) +35,000 35,000
2021-12-14 Dekker C. Jeffrey Chief Financial Officer Grant or award · Stock Option (right to buy) +17,700 17,700
2021-12-14 BRISTOW MICHAEL R Pres. & Chief Executive Offic Grant or award · Stock Option (right to buy) +95,000 95,000
2021-11-22 Ozeroff Christopher David S.V.P., General Counsel Purchase +50,000 $2.26 $113K 50,970
2021-05-12 CONWAY ROBERT E Director Purchase +10,000 $3.19 $32K 50,000
2021-05-05 CONWAY ROBERT E Director Purchase +10,000 $3.23 $32K 40,000
2021-01-12 Hove Anders D Director Grant or award · Stock Option (right to buy) +12,000 12,000
2021-01-12 Woosley Raymond L. Director Grant or award · Stock Option (right to buy) +12,000 12,000
2021-01-12 Grais Linda Director Grant or award · Stock Option (right to buy) +12,000 12,000
2021-01-12 MITCHELL DANIEL J Director Grant or award · Stock Option (right to buy) +12,000 12,000
2021-01-12 CONWAY ROBERT E Director Grant or award · Stock Option (right to buy) +12,000 12,000
2020-12-21 Keuer Thomas A Chief Operating Officer Grant or award · Stock Option (right to buy) +70,000 70,000
2020-12-21 Ozeroff Christopher David S.V.P., General Counsel Grant or award · Stock Option (right to buy) +55,000 55,000
2020-12-21 BRISTOW MICHAEL R Pres. & Chief Executive Offic Grant or award · Stock Option (right to buy) +190,000 190,000

Page 19 of 24 · 473 trades